{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:36:44Z","timestamp":1786649804412,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background\/Aim:<\/jats:title>\n                    <jats:p>This study aimed to assess the clinical outcomes of normal-tension glaucoma (NTG) in real-world clinical practice, focusing on the clinical profile, pattern of treatment preferences, and visual field progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A total of 875 eyes (476 patients) with NTG were included, with a mean age of 68 \u00b1 10.6 years. Of these, 77 eyes had unilateral NTG and 399 had bilateral NTG. Ocular\/systemic associations were recorded, and clinical variables, including the number of medications, intraocular pressure (IOP), and visual field parameters, were retrieved. Treatment options to achieve target IOP included topical medications (monotherapy or combination therapy) and surgical interventions. Visual field progression on guided progression analysis was available in 496 eyes with reliable data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      At baseline, 45% of eyes had severe glaucoma (mean deviation, MD = -13 \u00b1 8.7 dB). While 92 eyes (including 5 unilateral NTG) were observed without medication, 783 eyes were on initiated on topical medications. At a mean follow-up of 32 \u00b1 10.2 months, 22.2% of treated eyes showed visual field progression, compared to 10.8% in untreated eyes. The rate of progression in eyes that progressed was -2 \u00b1 0.9 dB per year versus 0.2 \u00b1 0.9 dB in stable eyes,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.003. Multivariate analysis did not reveal any clinical or systemic association that predicted visual field progression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study highlights the challenges of treating NTG in real-world clinical practice, where 45% patients presented with severe glaucoma. The absence of identifiable factors for progression suggests the need to search for newer risk factors for halting NTG progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_233_25","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T16:00:41Z","timestamp":1772035241000},"page":"433-437","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Real-world management patterns and outcomes in normal-tension glaucoma"],"prefix":"10.4103","volume":"74","author":[{"given":"Aparna","family":"Rao","sequence":"first","affiliation":[{"name":"Glaucoma Service, L. V. Prasad Eye Institute, Kallam Anji Reddy Campus, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Ray","sequence":"additional","affiliation":[{"name":"Glaucoma Service, L. V. Prasad Eye Institute, Kallam Anji Reddy Campus, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"R1-20260417","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/ceo.14043","article-title":"Normal-tension glaucoma: Current concepts and approaches-A review","volume":"50","author":"Leung","year":"2022","journal-title":"Clin Exp Ophthalmol"},{"key":"R2-20260417","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00055735-200304000-00006","article-title":"Collaborative normal tension glaucoma study","volume":"14","author":"Anderson","year":"2003","journal-title":"Curr Opin Ophthalmol"},{"key":"R3-20260417","first-page":"563","article-title":"Normal-tension glaucoma: Pathogenesis and genetics","volume":"17","author":"Trivli","year":"2019","journal-title":"Exp Ther Med"},{"key":"R4-20260417","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0002-9394(98)00272-4","article-title":"The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma","volume":"126","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"R5-20260417","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0002-9394(01)00964-3","article-title":"Collaborative normal-tension glaucoma study group: Risk factors for progression of visual field abnormalities in normal-tension glaucoma","volume":"131","author":"Drance","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R6-20260417","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jcjo.2016.08.011","article-title":"Risk factors for visual field progression of normal-tension glaucoma in patients with myopia","volume":"52","author":"Bae","year":"2017","journal-title":"Can J Ophthalmol"},{"key":"R7-20260417","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jcjo.2016.12.008","article-title":"Normal tension glaucoma management: A survey of contemporary practice","volume":"52","author":"Symes","year":"2017","journal-title":"Can J Ophthalmol"},{"key":"R8-20260417","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/11206721241247428","article-title":"The need for more pragmatic trials in glaucoma research","volume":"35","author":"Pacovska","year":"2025","journal-title":"Eur J Ophthalmol"},{"key":"R9-20260417","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2147\/OPTH.S146455","article-title":"Long-term progression of visual field defects and related factors in medically treated normal tension glaucoma","volume":"12","author":"Yoshikawa","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"R10-20260417","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1167\/iovs.10-5351","article-title":"Characteristics of visual field progression in medically treated normal-tension glaucoma patients with unstable ocular perfusion pressure","volume":"52","author":"Sung","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R11-20260417","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1167\/iovs.65.3.28","article-title":"Natural history and risk factors for glaucoma progression in Chinese patients with normal-tension glaucoma","volume":"65","author":"Chen","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R12-20260417","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ajo.2019.08.023","article-title":"Clinical course and risk factors for visual field progression in normal-tension glaucoma with myopia without glaucoma medications","volume":"209","author":"Han","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"R13-20260417","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s10384-017-0519-8","article-title":"Impact of intraocular pressure reduction on visual field progression in normal-tension glaucoma followed up over 15 years","volume":"61","author":"Oie","year":"2017","journal-title":"Jpn J Ophthalmol"},{"key":"R14-20260417","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10792-014-0020-z","article-title":"Differences in corneal parameters between normal tension glaucoma and primary open-angle glaucoma","volume":"35","author":"Lee","year":"2015","journal-title":"Int Ophthalmol"},{"key":"R15-20260417","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/bjo.2003.032110","article-title":"Ocular blood flow alteration in glaucoma is related to systemic vascular dysregulation","volume":"88","author":"Emre","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"R16-20260417","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1167\/iovs.10-6710","article-title":"Systemic vascular dysregulation and retrobulbar hemodynamics in normal-tension glaucoma","volume":"52","author":"Galassi","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R17-20260417","doi-asserted-by":"crossref","first-page":"e0287661","DOI":"10.1371\/journal.pone.0287661","article-title":"Effect of myopia on the progression of normal tension glaucoma","volume":"18","author":"Hsueh","year":"2023","journal-title":"PLoS One"},{"key":"R18-20260417","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/bjophthalmol-2019-315441","article-title":"Impact of myopia on the association of long-term intraocular pressure fluctuation with the rate of progression in normal-tension glaucoma","volume":"105","author":"Lee","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"R19-20260417","doi-asserted-by":"crossref","first-page":"e762","DOI":"10.1111\/aos.16644","article-title":"Longitudinal changes in optical coherence tomography angiography characteristics in normal-tension glaucoma with or without high myopia","volume":"102","author":"Lai","year":"2024","journal-title":"Acta Ophthalmol"},{"key":"R20-20260417","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ajo.2009.12.033","article-title":"Influence of the extent of myopia on the progression of normal-tension glaucoma","volume":"149","author":"Sohn","year":"2010","journal-title":"Am J Ophthalmol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_233_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:58:36Z","timestamp":1786647516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_233_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_233_25","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"2025-01-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}